Clinical Trials

We have both prevention and symptomatic trials. Our current prevention trial is listed at the top, followed by our symptomatic trials.

If you have been diagnosed with Mild Cognitive Impairment (MCI) or early onset Alzheimer’s disease, please consider our study. An FDA-approved antiretroviral HIV medication called Efavirenz will be given to participants to investigate if it can reduce cholesterol in the brain and alter the progression of Alzheimer’s disease.